All News

The authors say that this formula-which focuses on the size of both the baby and the mother-allows obstetricians to determine which women are at greatest risk for shoulder dystocia with permanent brachial plexus injury.

Most studies suggest that certain oral hypoglycemic agents can be safely used in pregnancy. If patients are unable to commit to or be adherent to insulin therapy, oral glyburide may be an appropriate alternative.

Recent articles attest to a growing interest in an alternative way to provide reimbursement for health-care services in both the United States and Great Britain. Individual physicians, multispecialty groups, and hospitals are rewarded for meeting pre-established quality and/or expense targets for their services.

Questions this month have been answered by:Barry Lee Gruber, MD OBGYN.net Editorial Advisor Maria Luisa Bianchi, MD, OBGYN.net Osteoporosis Editorial Advisor

New Products

The latest in medical products for obstetrics and gynecology.

Evidence for the "stress test" theory suggests that women with a history of preeclampsia, spontaneous abortion, preterm delivery, or delivery of a low birthweight infant are at increased risk for future disease. Knowing this in advance could allow physicians to address the problems women may face early enough so that they can still benefit from lifestyle and pharmacologic interventions.

One out of five teens and adults has genital herpes-many of them women. How can you help stem the epidemic? By identifying patients at risk for acquiring and transmitting herpes simplex virus using type-specific serologic tests, say these experts.

When diagnostic films, labs, and pathology are unavailable or inconclusive, a physician certainly has the right to rely upon his or her clinical evaluation in rendering a differential diagnosis and recommending treatment. But when physicians make a decision not to use such diagnostic tools-particularly for economic reasons-the clinical evaluation they choose to rely upon had best be eminently reasonable, if not entirely accurate.

I must admit I was very skeptical when I first heard that the NICHD Maternal-Fetal Medicine Units Network was going to conduct a randomized clinical trial of 17-hydroxyprogesterone caproate for the prevention of prematurity. . .

This month's questions answered by:Harvey S. Marchbein, MD,Chairman, Editorial Advisory Board,Osteoporosis Section, OBGYN.netRonald Barentsen, MD, PhD,Member, Editorial Advisory Board,Osteoporosis Section, OBGYN.net

September 15 Case Summaries

Clinical situations that typically result in litigation and the variation in jury verdicts and awards across the nation.

At some point you may need to consider merging the practice into a hospital or larger group. Like all processses of growth, merging medical practices can involve risk and a certain amount of pain. Here's how to prepare yourself for the transition.